Clinical trial
Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular…
NCT00115700 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00115700 |
|---|---|
| Title | Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma |
| Official title | A Randomised Multicentre Trial of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in Combination With Rituximab (Mabthera®) for Stage I - II Low Grade Follicular Lymphoma |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Australasian Leukaemia and Lymphoma Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Follicular Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | Cyclophosphamide, Radiotherapy, Vincristine, Prednisolone, Rituximab |
| Enrollment | 150 |
| Start date | Feb 1, 2000 |
| Primary completion | Aug 1, 2018 |
| Completion | Aug 1, 2018 |
| First posted | Jun 24, 2005 |
| Last update posted | Nov 18, 2022 |
| Countries | Australia, Canada, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: